RxNorm Semantic Concepts Index - 191
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "191".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 1910 | calcium hydroxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1910742 | Dust mite protein | Designated preferred name (PT) | NO | |
| RxCUI: 1910742 | Dust mite protein | Full form of descriptor (FN) | NO | |
| RxCUI: 19109 | Beta 2 glycoprotein I | Designated preferred name (PT) | NO | |
| RxCUI: 19109 | Beta 2 glycoprotein I | Full form of descriptor (FN) | NO | |
| RxCUI: 19109 | Beta 2 glycoprotein I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 19109 | Beta 2 glycoprotein I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1911 | calcium iopodate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1911 | calcium iopodate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 19111 | Beta lysin | Designated preferred name (PT) | NO | |
| RxCUI: 19111 | Beta lysin | Full form of descriptor (FN) | NO | |
| RxCUI: 1911407 | Filgotinib | Designated preferred name (PT) | NO | |
| RxCUI: 1911407 | Filgotinib | Full form of descriptor (FN) | NO | |
| RxCUI: 1911407 | Filgotinib | Designated preferred name (PT) | NO | |
| RxCUI: 1911407 | Filgotinib | Full form of descriptor (FN) | NO | |
| RxCUI: 191166 | Technetium (99m-Tc) albumin | Designated preferred name (PT) | NO | |
| RxCUI: 191166 | Technetium (99m-Tc) albumin | Full form of descriptor (FN) | NO | |
| RxCUI: 19123 | N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III | Designated preferred name (PT) | NO | |
| RxCUI: 19123 | N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III | Full form of descriptor (FN) | NO | |
| RxCUI: 19123 | N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 19128 | Beta-adrenergic receptor kinase | Designated preferred name (PT) | NO | |
| RxCUI: 19128 | Beta-adrenergic receptor kinase | Full form of descriptor (FN) | NO | |
| RxCUI: 191332 | Decafluorobutane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 191332 | Decafluorobutane | Designated preferred name (PT) | NO | |
| RxCUI: 191332 | Decafluorobutane | Full form of descriptor (FN) | NO | |
| RxCUI: 191332 | Decafluorobutane | Designated preferred name (PT) | NO | |
| RxCUI: 191332 | Decafluorobutane | Full form of descriptor (FN) | NO | |
| RxCUI: 19134 | Beta-aspartyl-N-acetylglucosaminidase | Designated preferred name (PT) | NO | |
| RxCUI: 19134 | Beta-aspartyl-N-acetylglucosaminidase | Full form of descriptor (FN) | NO | |
| RxCUI: 191362 | Lymphocyte antigen CD85 | Designated preferred name (PT) | NO | |
| RxCUI: 191362 | Lymphocyte antigen CD85 | Full form of descriptor (FN) | NO | |
| RxCUI: 19143 | Beta-carotene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 19143 | Beta-carotene | Designated preferred name (PT) | YES | |
| RxCUI: 19143 | Beta-carotene | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 19143 | Beta-carotene | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 19143 | Beta-carotene | Full form of descriptor (FN) | YES | |
| RxCUI: 19143 | Beta-carotene | Designated preferred name (PT) | YES | |
| RxCUI: 19143 | Beta-carotene | Full form of descriptor (FN) | YES | |
| RxCUI: 19143 | Beta-carotene | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 19144 | Beta-carotene 15,15'-dioxygenase | Designated preferred name (PT) | NO | |
| RxCUI: 19144 | Beta-carotene 15,15'-dioxygenase | Full form of descriptor (FN) | NO | |
| RxCUI: 19153 | Beta-cyanoalanine synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 19153 | Beta-cyanoalanine synthase | Designated preferred name (PT) | NO | |
| RxCUI: 19153 | Beta-cyanoalanine synthase | Full form of descriptor (FN) | NO | |
| RxCUI: 19156 | Invertase | Designated preferred name (PT) | NO | |
| RxCUI: 19156 | Invertase | Full form of descriptor (FN) | NO | |
| RxCUI: 19156 | Invertase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 19156 | Invertase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 191566 | climbazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 191566 | climbazole | Designated preferred name (PT) | NO | |
| RxCUI: 191566 | climbazole | Full form of descriptor (FN) | NO | |
| RxCUI: 191566 | climbazole | Designated preferred name (PT) | NO | |
| RxCUI: 191566 | climbazole | Full form of descriptor (FN) | NO | |
| RxCUI: 19157 | Beta-D-fucosidase | Designated preferred name (PT) | NO | |
| RxCUI: 19157 | Beta-D-fucosidase | Full form of descriptor (FN) | NO | |
| RxCUI: 19159 | Mannanase | Designated preferred name (PT) | NO | |
| RxCUI: 19159 | Mannanase | Full form of descriptor (FN) | NO | |
| RxCUI: 19159 | Mannanase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 19159 | Mannanase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 191603 | Aquaporin-8 | Designated preferred name (PT) | NO | |
| RxCUI: 191603 | Aquaporin-8 | Full form of descriptor (FN) | NO | |
| RxCUI: 191623 | Alpha-methylacyl-coenzyme A racemase | Designated preferred name (PT) | NO | |
| RxCUI: 191623 | Alpha-methylacyl-coenzyme A racemase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 191623 | Alpha-methylacyl-coenzyme A racemase | Full form of descriptor (FN) | NO | |
| RxCUI: 1917 | calcium pangamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1918 | Calcium pantothenate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1918 | Calcium pantothenate | Designated preferred name (PT) | YES | |
| RxCUI: 1918 | Calcium pantothenate | Full form of descriptor (FN) | YES | |
| RxCUI: 1918039 | camphor 10 % / menthol 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1918039 | camphor 10 % / menthol 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1918039 | camphor 10 % / menthol 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1918040 | zedoary oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1918041 | abiraterone acetate 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1918042 | abiraterone acetate 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1918042 | abiraterone acetate 500 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1918042 | abiraterone acetate 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1918042 | abiraterone acetate 500 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1918043 | abiraterone acetate 500 MG [Zytiga] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1918044 | Zytiga 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1918044 | Zytiga 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1918044 | Zytiga 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918045 | DOCEtaxel 200 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1918045 | DOCEtaxel 200 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1918045 | DOCEtaxel 200 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1918045 | DOCEtaxel 200 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1918045 | DOCEtaxel 200 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1918046 | Illicium anisatum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1918048 | Rhododendron ferrugineum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1918052 | PEG-20 sorbitan stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1918053 | polygalacturonic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1918054 | polygalacturonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1918055 | pigment green 7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1918056 | Simpesse 91 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1918056 | Simpesse 91 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1918056 | Simpesse 91 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918192 | fluticasone propionate 0.113 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1918194 | fluticasone propionate/salmeterol 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1918194 | fluticasone propionate/salmeterol 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918194 | fluticasone propionate/salmeterol 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1918195 | AirDuo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1918197 | fluticasone / salmeterol Dry Powder Inhaler [AirDuo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1918198 | AirDuo Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1918199 | AirDuo RespiClick 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1918199 | AirDuo RespiClick 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918199 | AirDuo RespiClick 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918199 | AirDuo RespiClick 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1918200 | fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1918201 | fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler [AirDuo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1918202 | fluticasone propionate 0.232 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1918203 | fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1918203 | fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918203 | fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1918205 | AirDuo RespiClick 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1918205 | AirDuo RespiClick 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918205 | AirDuo RespiClick 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918205 | AirDuo RespiClick 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1918206 | fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1918207 | fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler [AirDuo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1918208 | fluticasone propionate 0.055 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1918209 | fluticasone propionate/salmeterol 55/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1918209 | fluticasone propionate/salmeterol 55/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918209 | fluticasone propionate/salmeterol 55/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1918211 | AirDuo RespiClick 55/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1918211 | AirDuo RespiClick 55/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918211 | AirDuo RespiClick 55/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918211 | AirDuo RespiClick 55/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1918212 | fluticasone propionate 0.055 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1918213 | fluticasone propionate 0.055 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler [AirDuo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1918214 | chlorhexidine gluconate 2 % / isopropyl alcohol 70 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1918214 | chlorhexidine gluconate 2 % / isopropyl alcohol 70 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1918214 | chlorhexidine gluconate 2 % / isopropyl alcohol 70 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1918214 | chlorhexidine gluconate 2 % / isopropyl alcohol 70 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1918215 | carbinoxamine maleate 2 MG/mL / dextromethorphan HBr 4 MG/mL / pseudoephedrine HCl 25 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1918215 | carbinoxamine maleate 2 MG/mL / dextromethorphan HBr 4 MG/mL / pseudoephedrine HCl 25 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1918215 | carbinoxamine maleate 2 MG/mL / dextromethorphan HBr 4 MG/mL / pseudoephedrine HCl 25 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1918217 | pseudoephedrine Oral Capsule [Zephrex-D] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1918218 | Zephrex-D 30 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1918218 | Zephrex-D 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1918218 | Zephrex-D 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918219 | valbenazine | Full form of descriptor (FN) | YES | |
| RxCUI: 1918219 | valbenazine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1918219 | valbenazine | Designated preferred name (PT) | YES | |
| RxCUI: 1918219 | valbenazine | Full form of descriptor (FN) | YES | |
| RxCUI: 1918219 | valbenazine | Designated preferred name (PT) | YES | |
| RxCUI: 1918220 | valbenazine 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1918221 | valbenazine Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1918221 | valbenazine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1918221 | valbenazine Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1918222 | valbenazine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1918223 | valbenazine Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1918224 | valbenazine 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918224 | valbenazine 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1918224 | valbenazine 40 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1918225 | Ingrezza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1918226 | valbenazine 40 MG [Ingrezza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1918227 | valbenazine Oral Capsule [Ingrezza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1918228 | Ingrezza Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1918229 | Ingrezza Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1918230 | INGREZZA 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918230 | INGREZZA 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1918230 | INGREZZA 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918230 | INGREZZA 40 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1918231 | niraparib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1918231 | niraparib | Designated preferred name (PT) | YES | |
| RxCUI: 1918231 | niraparib | Full form of descriptor (FN) | YES | |
| RxCUI: 1918231 | niraparib | Designated preferred name (PT) | YES | |
| RxCUI: 1918231 | niraparib | Full form of descriptor (FN) | YES | |
| RxCUI: 1918232 | niraparib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1918233 | niraparib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1918233 | niraparib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1918233 | niraparib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1918234 | niraparib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1918235 | niraparib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1918236 | niraparib 100 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1918236 | niraparib 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918236 | niraparib 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1918236 | niraparib 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1918236 | niraparib 100 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1918237 | Zejula | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1918238 | niraparib 100 MG [Zejula] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1918239 | niraparib Oral Capsule [Zejula] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1918240 | Zejula Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1918241 | Zejula Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1918242 | Zejula 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1918242 | Zejula 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1918242 | Zejula 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1918243 | Ginkgo biloba root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1918244 | Panax ginseng leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1918245 | acrylate/isobutyl methacrylate/N-tert-octylacrylamide copolymer (75000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1918251 | sodium fluoride 0.0008 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1918252 | sodium fluoride 0.08 % / sodium monofluorophosphate 0.4 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1918252 | sodium fluoride 0.08 % / sodium monofluorophosphate 0.4 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1918252 | sodium fluoride 0.08 % / sodium monofluorophosphate 0.4 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 191826 | Zeta-crystallin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 191831 | infliximab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 191831 | infliximab | Designated preferred name (PT) | YES | |
| RxCUI: 191831 | infliximab | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 191831 | infliximab | Full form of descriptor (FN) | YES | |
| RxCUI: 191831 | infliximab | Designated preferred name (PT) | YES | |
| RxCUI: 191831 | infliximab | Full form of descriptor (FN) | YES | |
| RxCUI: 1918319 | Biguanide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1918319 | Biguanide | Designated preferred name (PT) | NO | |
| RxCUI: 1918319 | Biguanide | Full form of descriptor (FN) | NO | |
| RxCUI: 1918319 | Biguanide | Designated preferred name (PT) | NO | |
| RxCUI: 1918319 | Biguanide | Full form of descriptor (FN) | NO | |
| RxCUI: 1918320 | low-substituted hydroxypropyl cellulose (11% hydroxypropyl; 120000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1918451 | Cryptomeria japonica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1918453 | benzalkonium chloride 0.1 % / benzocaine 20 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1918453 | benzalkonium chloride 0.1 % / benzocaine 20 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1918453 | benzalkonium chloride 0.1 % / benzocaine 20 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1919 | calcium phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1919 | calcium phosphate | Designated preferred name (PT) | YES | |
| RxCUI: 1919 | calcium phosphate | Full form of descriptor (FN) | YES | |
| RxCUI: 1919 | calcium phosphate | Designated preferred name (PT) | YES | |
| RxCUI: 1919 | calcium phosphate | Full form of descriptor (FN) | YES | |
| RxCUI: 1919068 | Dormin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1919069 | diphenhydramine hydrochloride 25 MG [Dormin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1919069 | diphenhydramine hydrochloride 25 MG [Dormin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1919070 | diphenhydrAMINE Oral Capsule [Dormin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1919070 | diphenhydrAMINE Oral Capsule [Dormin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1919071 | Dormin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1919072 | Dormin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1919073 | Dormin 25 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1919073 | Dormin 25 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1919073 | Dormin 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1919073 | Dormin 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1919076 | acetaminophen 325 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1919076 | acetaminophen 325 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1919076 | acetaminophen 325 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1919076 | acetaminophen 325 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1919076 | acetaminophen 325 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1919083 | midostaurin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1919083 | midostaurin | Designated preferred name (PT) | YES | |
| RxCUI: 1919083 | midostaurin | Full form of descriptor (FN) | YES | |
| RxCUI: 1919083 | midostaurin | Designated preferred name (PT) | YES | |
| RxCUI: 1919083 | midostaurin | Full form of descriptor (FN) | YES | |
| RxCUI: 1919084 | midostaurin 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1919085 | midostaurin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1919085 | midostaurin Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1919085 | midostaurin Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1919086 | midostaurin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1919087 | midostaurin Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1919088 | midostaurin 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1919088 | midostaurin 25 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1919088 | midostaurin 25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1919088 | midostaurin 25 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1919089 | Rydapt | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1919090 | midostaurin 25 MG [Rydapt] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1919091 | midostaurin Oral Capsule [Rydapt] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1919092 | Rydapt Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1919093 | Rydapt Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1919094 | Rydapt 25 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1919094 | Rydapt 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1919094 | Rydapt 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 19191 | 3-hydroxyisobutyrate dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 19191 | 3-hydroxyisobutyrate dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 1919206 | thiotepa 100 MG [Tepadina] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1919207 | thiotepa Injection [Tepadina] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1919208 | Tepadina Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1919209 | TEPADINA 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1919209 | TEPADINA 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1919209 | TEPADINA 100 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1919209 | TEPADINA 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1919210 | thiotepa 15 MG [Tepadina] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1919211 | TEPADINA 15 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1919211 | TEPADINA 15 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1919211 | TEPADINA 15 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1919211 | TEPADINA 15 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1919485 | cholecalciferol 9.52 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1919486 | glucose 357 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1919487 | cholecalciferol / glucose Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1919488 | cholecalciferol / glucose Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1919489 | glucose 15 GM / vitamin D3 400 UNT in 42 mL Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1919489 | glucose 15 GM / vitamin D3 400 UNT in 42 mL Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1919489 | glucose 15 GM / vitamin D3 400 UNT in 42 mL Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1919489 | glucose 15 GM / vitamin D3 400 UNT in 42 mL Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1919492 | 2-hydroxyacetophenone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1919495 | Caprieve | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1919496 | carprofen 100 MG [Caprieve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1919497 | carprofen Chewable Tablet [Caprieve] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1919498 | Caprieve Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1919499 | Caprieve Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1919500 | Caprieve Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1919501 | Caprieve 100 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1919501 | Caprieve 100 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1919501 | Caprieve 100 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1919503 | durvalumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1919503 | durvalumab | Designated preferred name (PT) | YES | |
| RxCUI: 1919503 | durvalumab | Full form of descriptor (FN) | YES | |
| RxCUI: 1919503 | durvalumab | Designated preferred name (PT) | YES | |
| RxCUI: 1919503 | durvalumab | Full form of descriptor (FN) | YES | |
| RxCUI: 1919504 | durvalumab 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1919505 | durvalumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1919505 | durvalumab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 1919505 | durvalumab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1919506 | durvalumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1919507 | durvalumab 120 in 2.4 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1919507 | durvalumab 120 in 2.4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1919507 | durvalumab 120 in 2.4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1919508 | Imfinzi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1919509 | durvalumab 50 MG/ML [Imfinzi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1919510 | durvalumab Injection [Imfinzi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1919511 | Imfinzi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1919512 | IMFINZI 120 MG in 2.4 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1919512 | IMFINZI 120 MG in 2.4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1919512 | IMFINZI 120 MG in 2.4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1919512 | IMFINZI 120 MG in 2.4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1919513 | durvalumab 50 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1919514 | durvalumab 50 MG/ML Injection [Imfinzi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1919514 | durvalumab 50 MG/ML Injection [Imfinzi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1919515 | durvalumab 500 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1919515 | durvalumab 500 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1919515 | durvalumab 500 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1919516 | IMFINZI 500 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1919516 | IMFINZI 500 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1919516 | IMFINZI 500 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1919516 | IMFINZI 500 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1919517 | carprofen Chewable Tablet [Novox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1919518 | Novox Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1919519 | Novox 100 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1919519 | Novox 100 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1919519 | Novox 100 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1919520 | carprofen Chewable Tablet [OstiFen] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1919521 | OstiFen Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1919522 | OstiFen 100 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1919522 | OstiFen 100 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1919522 | OstiFen 100 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1919523 | carprofen 25 MG [Caprieve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1919524 | Caprieve 25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1919524 | Caprieve 25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1919524 | Caprieve 25 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1919525 | Novox 25 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1919525 | Novox 25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1919525 | Novox 25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1919526 | OstiFen 25 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1919526 | OstiFen 25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1919526 | OstiFen 25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1919527 | carprofen 75 MG [Caprieve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1919528 | Caprieve 75 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1919528 | Caprieve 75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1919528 | Caprieve 75 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1919529 | Novox 75 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1919529 | Novox 75 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1919529 | Novox 75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1919530 | OstiFen 75 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1919530 | OstiFen 75 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1919530 | OstiFen 75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1919588 | ascorbic acid / iron carbonyl Delayed Release Oral Tablet [Vitron-C Reformulated Jul 2016] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |